CDK6 and non-small cell lung carcinoma: Guo has reported that FOXD3-AS1 is overexpressed in non-small cell lung cancer, and FOXD3-AS1 upregulation promotes the tumor progression by regulating the miR-135a-5p/CDK6 axis in non-small cell lung cancer31.